Literature DB >> 29385540

Measurement of Human Immunodeficiency Virus p24 Antigen in Human Cerebrospinal Fluid With Digital Enzyme-Linked Immunosorbent Assay and Association With Decreased Neuropsychological Performance.

Albert M Anderson1, William R Tyor2,3, Mark J Mulligan1, Drenna Waldrop-Valverde4, Jeffrey L Lennox1, Scott L Letendre5.   

Abstract

New tools are needed to understand human immunodeficiency virus central nervous system involvement. Testing 15 cerebrospinal fluid (CSF) samples for p24 antigen, using a high-sensitivity assay, we found a strong correlation trend between CSF p24 concentration and worse neuropsychological performance.

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29385540      PMCID： PMC6005050          DOI： 10.1093/cid/ciy056

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN： 1058-4838            Impact factor:   20.999


  12 in total

1.  Ultrasensitive HIV-1 p24 Assay Detects Single Infected Cells and Differences in Reservoir Induction by Latency Reversal Agents.

Authors:  Caroline Pereira Bittencourt Passaes; Timothée Bruel; Jérémie Decalf; Annie David; Mathieu Angin; Valerie Monceaux; Michaela Muller-Trutwin; Nicolas Noel; Katia Bourdic; Olivier Lambotte; Matthew L Albert; Darragh Duffy; Olivier Schwartz; Asier Sáez-Cirión
Journal:  J Virol       Date:  2017-02-28       Impact factor: 5.103

2.  The level of human immunodeficiency virus (HIV) type 1 RNA in cerebrospinal fluid as a marker of HIV encephalitis.

Authors:  P Bossi; N Dupin; A Coutellier; F Bricaire; C Lubetzki; C Katlama; V Calvez
Journal:  Clin Infect Dis       Date:  1998-05       Impact factor: 9.079

3.  Cerebrospinal fluid HIV-1 p24 antigen and culture: sensitivity and specificity for AIDS-dementia complex.

Authors:  B J Brew; M O Paul; G Nakajima; A Khan; H Gallardo; R W Price
Journal:  J Neurol Neurosurg Psychiatry       Date:  1994-07       Impact factor: 10.154

4.  Cerebrospinal fluid HIV escape associated with progressive neurologic dysfunction in patients on antiretroviral therapy with well controlled plasma viral load.

Authors:  Michael J Peluso; Francesca Ferretti; Julia Peterson; Evelyn Lee; Dietmar Fuchs; Antonio Boschini; Magnus Gisslén; Nancy Angoff; Richard W Price; Paola Cinque; Serena Spudich
Journal:  AIDS       Date:  2012-09-10       Impact factor: 4.177

5.  Prevalence and Correlates of Persistent HIV-1 RNA in Cerebrospinal Fluid During Antiretroviral Therapy.

Authors:  Albert M Anderson; Jose A Muñoz-Moreno; Daniel R McClernon; Ronald J Ellis; Debra Cookson; David B Clifford; Ann C Collier; Benjamin B Gelman; Christina M Marra; Justin C McArthur; J Allen McCutchan; Susan Morgello; Ned Sacktor; David M Simpson; Donald R Franklin; Robert K Heaton; Igor Grant; Scott L Letendre
Journal:  J Infect Dis       Date:  2016-10-26       Impact factor: 5.226

6.  Determining optimal impairment rating methodology for a new HIV-associated neurocognitive disorder screening procedure.

Authors:  Jody Kamminga; Mark Bloch; Trina Vincent; Angela Carberry; Bruce J Brew; Lucette A Cysique
Journal:  J Clin Exp Neuropsychol       Date:  2017-01-04       Impact factor: 2.475

7.  Normative data and validation of a regression based summary score for assessing meaningful neuropsychological change.

Authors:  Lucette A Cysique; Donald Franklin; Ian Abramson; Ronald J Ellis; Scott Letendre; Ann Collier; David Clifford; Benjamin Gelman; Justin McArthur; Susan Morgello; David Simpson; J Allen McCutchan; Igor Grant; Robert K Heaton
Journal:  J Clin Exp Neuropsychol       Date:  2011-03-07       Impact factor: 2.475

8.  Simple diffusion-constrained immunoassay for p24 protein with the sensitivity of nucleic acid amplification for detecting acute HIV infection.

Authors:  Lei Chang; Linan Song; David R Fournier; Cheuk W Kan; Purvish P Patel; Evan P Ferrell; Brian A Pink; Kaitlin A Minnehan; David W Hanlon; David C Duffy; David H Wilson
Journal:  J Virol Methods       Date:  2012-10-02       Impact factor: 2.014

9.  Rapid serologic testing with immune-complex-dissociated HIV p24 antigen for early detection of HIV infection in neonates. Southern California Pediatric AIDS Consortium.

Authors:  S A Miles; E Balden; L Magpantay; L Wei; A Leiblein; D Hofheinz; G Toedter; E R Stiehm; Y Bryson
Journal:  N Engl J Med       Date:  1993-02-04       Impact factor: 91.245

10.  Discordance between cerebral spinal fluid and plasma HIV replication in patients with neurological symptoms who are receiving suppressive antiretroviral therapy.

Authors:  Ana Canestri; François-Xavier Lescure; Stephane Jaureguiberry; Antoine Moulignier; Corinne Amiel; Anne Geneviève Marcelin; Gilles Peytavin; Roland Tubiana; Gilles Pialoux; Christine Katlama
Journal:  Clin Infect Dis       Date:  2010-03-01       Impact factor: 9.079
View more
  1 in total

Review 1.  Soluble Biomarkers of Cognition and Depression in Adults with HIV Infection in the Combination Therapy Era.

Authors:  Albert M Anderson; Qing Ma; Scott L Letendre; Jennifer Iudicello
Journal:  Curr HIV/AIDS Rep       Date:  2021-11-15       Impact factor: 5.071
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.